Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Concomitant Administration ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Concomitant Administration ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.11.026 ◽

2006 ◽

Vol 24 (4) ◽

pp. 344-348 ◽

Cited By ~ 158

Author(s):

Fadi N. Joudi ◽

Brian J. Smith ◽

Michael A. O’Donnell

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Interferon Α ◽

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.03.010 ◽

2005 ◽

Vol 23 (3) ◽

pp. 218

Author(s):

William A. See

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Interferon Alfa ◽

INTERIM RESULTS FROM A NATIONAL MULTICENTER PHASE II TRIAL OF COMBINATION BACILLUS CALMETTE-GUERIN PLUS INTERFERON ALFA-2B FOR SUPERFICIAL BLADDER CANCER

10.1097/01.ju.0000136446.37840.0a ◽

2004 ◽

Vol 172 (3) ◽

pp. 888-893 ◽

Cited By ~ 69

Author(s):

MICHAEL A. O’DONNELL ◽

KATHLEEN LILLI ◽

CHRISTINA LEOPOLD ◽

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Interferon Alfa ◽

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer

Yearbook of Urology ◽

10.1016/s0084-4071(08)70108-8 ◽

2007 ◽

Vol 2007 ◽

pp. 137-138

Author(s):

A.S. Kibel

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Interferon Α ◽

203 PRELIMINARY RESULTS OF A PHASE II TRIAL OF IRINOTECAN (I) AND GEMCITABINE (G) IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER.

Journal of Investigative Medicine ◽

10.1136/jim-52-suppl1-756 ◽

2004 ◽

Vol 52 (Suppl 1) ◽

pp. S293.3-S293

Author(s):

U B Chaudhary ◽

S Shannon ◽

N Curry ◽

T E Keane ◽

R T Means

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Preliminary Results ◽

Metastatic Bladder Cancer

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

10.1016/j.juro.2013.03.097 ◽

2013 ◽

Vol 190 (3) ◽

pp. 857-862 ◽

Cited By ~ 25

Author(s):

Paolo Gontero ◽

Marco Oderda ◽

Anja Mehnert ◽

Alberto Gurioli ◽

Francesco Marson ◽

...

Keyword(s):

Quality Of Life ◽

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Instillation Therapy ◽

Randomized Phase Ii ◽

The Impact ◽

Nonmuscle Invasive Bladder Cancer

Commentary on “The impact of intravesical gemcitabine and 1/3 dose bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: Results of a prospective, randomized, phase II trial.” Gontero P, Oderda M, Mehnert A, Gurioli A, Marson F, Lucca I, Rink M, Schmid M, Kluth LA, Pappagallo G, Sogni F, Sanguedolce F, Schiavina R, Martorana G, Shariat SF, Chun F.

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2014.03.021 ◽

2015 ◽

Vol 33 (1) ◽

pp. 46-47

Author(s):

Ashish Kamat

Keyword(s):

Quality Of Life ◽

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Instillation Therapy ◽

Randomized Phase Ii ◽

The Impact ◽

Nonmuscle Invasive Bladder Cancer

Evaluation of an Unconventional Treatment Modality with Mistletoe Lectin to Prevent Recurrence of Superficial Bladder Cancer: A Randomized Phase ii Trial

10.1016/s0022-5347(05)64834-3 ◽

2002 ◽

Vol 168 (1) ◽

pp. 72-75 ◽

Cited By ~ 24

Author(s):

Peter J. Goebell ◽

Thomas Otto ◽

Julia Suhr ◽

Herbert Rübben

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Treatment Modality ◽

Phase Ii Trial ◽

Mistletoe Lectin ◽

Randomized Phase Ii

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin

10.1016/j.juro.2013.04.031 ◽

2013 ◽

Vol 190 (4) ◽

pp. 1200-1204 ◽

Cited By ~ 81

Author(s):

Eila C. Skinner ◽

Bryan Goldman ◽

Wael A. Sakr ◽

Daniel P. Petrylak ◽

Heinz-Josef Lenz ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Invasive Bladder Cancer ◽

Nonmuscle Invasive Bladder Cancer